blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3421493

EP3421493 - MONOCLONAL ANTIBODIES TO PROGASTRIN AND THEIR USES [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  15.12.2023
Database last updated on 31.08.2024
FormerGrant of patent is intended
Status updated on  16.08.2023
FormerExamination is in progress
Status updated on  30.03.2020
FormerRequest for examination was made
Status updated on  05.07.2019
FormerThe application has been published
Status updated on  30.11.2018
Most recent event   Tooltip19.07.2024Lapse of the patent in a contracting state
New state(s): HR, RS
published on 21.08.2024  [2024/34]
Applicant(s)For all designated states
Progastrine et Cancers S.à r.l.
11, Côte d'Eich
1450 Luxembourg / LU
For all designated states
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
3, rue Michel Ange
75016 Paris / FR
For all designated states
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, rue de Tolbiac
75013 Paris / FR
[2019/01]
Inventor(s)01 / PANNEQUIN, Julie
13 rue Henri Barbusse
34200 Sète / FR
02 / BOUDIER, Laure
Batiment 0, Appartment 69
Residence "Les Jardins du Pere Soulas"
76 Rue de St Priest
34090 Montpellier / FR
03 / JOUBERT, Dominique
10 rue Gabriel Péri
34200 Sète / FR
04 / HOLLANDE, Frédéric
63 chemin de la Deridiere
34270 Les Matelles / FR
 [2019/01]
Representative(s)Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[2019/01]
Application number, filing date18185172.615.10.2010
[2019/01]
Priority number, dateUS200925262509P16.10.2009         Original published format: US 25262509 P
[2019/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3421493
Date:02.01.2019
Language:EN
[2019/01]
Type: B1 Patent specification 
No.:EP3421493
Date:17.01.2024
Language:EN
[2024/03]
Search report(s)(Supplementary) European search report - dispatched on:EP29.11.2018
ClassificationIPC:C07K16/26, A61K39/395, A61P35/00
[2019/01]
CPC:
C07K16/26 (EP,IL,KR,US); A61K39/395 (IL); A61P1/00 (EP);
A61P35/00 (EP,IL); G01N33/57419 (IL,US); G01N33/57488 (IL,US);
A61K2039/505 (EP,IL,US); C07K2317/24 (EP,US); C07K2317/33 (EP,IL,US);
C07K2317/34 (EP,US); C07K2317/565 (EP,US); C07K2317/567 (EP,US);
C07K2317/73 (EP,IL,US); C07K2317/76 (US); C07K2317/92 (EP,IL,US);
G01N2333/595 (IL,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/32]  
Former [2019/01]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBA01.07.2019
ME01.07.2019
TitleGerman:MONOKLONALE ANTIKÖRPER GEGEN PROGASTRIN UND VERWENDUNGEN DAVON[2019/01]
English:MONOCLONAL ANTIBODIES TO PROGASTRIN AND THEIR USES[2019/01]
French:ANTICORPS MONOCLONAUX CONTRE LA PROGASTRINE ET LEURS UTILISATIONS[2019/01]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure01.07.2019Amendment by applicant (claims and/or description)
01.07.2019Examination requested  [2019/32]
01.07.2019Date on which the examining division has become responsible
02.04.2020Despatch of a communication from the examining division (Time limit: M06)
07.10.2020Reply to a communication from the examining division
21.04.2021Despatch of a communication from the examining division (Time limit: M04)
30.08.2021Reply to a communication from the examining division
29.06.2023Cancellation of oral proceeding that was planned for 05.07.2023
05.07.2023Date of oral proceedings (cancelled)
17.08.2023Communication of intention to grant the patent
13.12.2023Fee for grant paid
13.12.2023Fee for publishing/printing paid
13.12.2023Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP10768878.0  / EP2488551
Fees paidRenewal fee
24.07.2018Renewal fee patent year 03
24.07.2018Renewal fee patent year 04
24.07.2018Renewal fee patent year 05
24.07.2018Renewal fee patent year 06
24.07.2018Renewal fee patent year 07
24.07.2018Renewal fee patent year 08
10.10.2018Renewal fee patent year 09
08.10.2019Renewal fee patent year 10
13.10.2020Renewal fee patent year 11
26.10.2021Renewal fee patent year 12
27.09.2022Renewal fee patent year 13
13.09.2023Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHR17.01.2024
RS17.04.2024
IS17.05.2024
[2024/34]
Former [2024/32]IS17.05.2024
Documents cited:Search[XY]WO2006032980  (APHTON CORP [US], et al);
 [XY]WO2007135542  (INST NAT SANTE RECH MED [FR], et al);
 [A]WO2008076454  (UNIV TEXAS [US]);
by applicantUS4399216
 US4510245
 US4634665
 EP0239400
 US4737456
 US4816567
 US4816397
 US4968615
 WO9109967
 WO9110741
 US5168062
 EP0519596
 US5179017
 US5219996
 WO9312227
 US5225539
 EP0592106
 US5530101
 US5545806
 US5565332
 US5585089
 US5658570
 US5681722
 US5693761
 US5693762
 US5693780
 US5807715
 EP0948544
 US6150584
 US6180370
 WO2007135542
 WO2008076454
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.